Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.

PUBLIC HEALTH REPORTS is a premier journal in the field of public health, published by SAGE PUBLICATIONS INC in the United States. With its ISSN 0033-3549 and E-ISSN 1468-2877, this esteemed publication has been an influential voice in the discipline since its inception in 1945. Recognized for its rigorous scholarship, it currently holds a distinguished Q1 ranking in the 2023 category of Public Health, Environmental and Occupational Health, emphasizing its significance with a Scopus rank of #186 out of 665, placing it in the 72nd percentile. The journal aims to disseminate high-quality research that addresses pressing health issues and promotes evidence-based practices, making it a vital resource for researchers, professionals, and students alike. Although it is not an open-access journal, PUBLIC HEALTH REPORTS continues to offer extensive insights and advancements pertinent to the global public health landscape, thereby fostering a deeper understanding and engagement with critical health determinants. Researchers and health practitioners are encouraged to contribute to this dynamic forum where knowledge and innovation converge.

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

Genome Medicine is a prestigious, peer-reviewed journal published by BMC, focusing on the rapidly evolving fields of genetics, molecular biology, and molecular medicine. Established in 2009 and boasting an open-access format, it has become a leading platform for disseminating high-quality research findings that advance our understanding of genetic diseases and therapeutic innovations. With an impressive Q1 ranking across multiple relevant categories—in particular, genetics (clinical), molecular biology, and molecular medicine—this journal is recognized for its substantial impact in the academic community, as evidenced by its exceptional placement in Scopus rankings. By providing unrestricted access to groundbreaking studies, Genome Medicine fosters collaboration and knowledge sharing among researchers, clinicians, and educators, thus playing a vital role in the transition from fundamental genetic research to clinical applications. Researchers are encouraged to contribute their findings and insights, further solidifying the journal’s position as a pivotal resource for those dedicated to advancing genomic medicine.

EPIDEMIOLOGIC REVIEWS, an esteemed publication from Oxford University Press Inc, stands as a beacon in the fields of Epidemiology and Medicine, with a significant focus on synthesizing and analyzing the latest research and developments in these areas since its inception in 1979. This journal, with its ISSN 0193-936X and E-ISSN 1478-6729, is recognized for its high academic rigor, boasting a 2023 Q1 quartile ranking in both Epidemiology and Miscellaneous Medicine, and ranks #25 out of 148 in Scopus's Epidemiology category, placing it in the prestigious 83rd percentile. Although it does not currently offer open access, its subscription options provide comprehensive access to a wealth of epidemiological knowledge, essential for researchers, public health professionals, and students keen on advancing their understanding of health trends and disease patterns. With a commitment to promoting high-quality research and impactful insights, EPIDEMIOLOGIC REVIEWS plays a crucial role in enhancing public health discourse and shaping future epidemiological inquiries.

The Canadian Journal of Public Health - Revue Canadienne de Santé Publique, published by Springer International Publishing AG, stands as a pivotal platform for scholarly discourse in the fields of public health and environmental health. With its esteemed position in the Q1 category for both Medicine (miscellaneous) and Public Health, the journal boasts an impressive Scopus ranking that places it within the 80th percentile, reflecting its contribution to advancing knowledge and best practices in public health since its inception in 1945. Situated in Switzerland, this journal serves a global audience of researchers, professionals, and students dedicated to improving public health outcomes. Although it offers traditional access options, its rigorous peer-review process ensures that high-quality research remains at the forefront of its publications. Whether addressing emerging health issues or environmental challenges, the journal plays a vital role in shaping the conversation and policies that influence health systems worldwide.

The Central European Journal of Public Health, ISSN 1210-7778 and E-ISSN 1803-1048, is a vital academic forum published by the NATIONAL INSTITUTE OF PUBLIC HEALTH, Czech Republic. With its comprehensive coverage of contemporary issues in public health and medicine since its inception in 1993, this journal aims to bridge the gap between research and practice, fostering a deeper understanding of health dynamics within Central Europe and beyond. As a Q3 ranked journal in both the fields of Medicine (miscellaneous) and Public Health, Environmental and Occupational Health as per 2023 metrics, it provides an accessible platform for innovative studies, policy analyses, and reviews that contribute to the global discourse on public health challenges. Though primarily based in the Czech Republic, it welcomes contributions from a worldwide audience, enhancing its scope and impact. Researchers, practitioners, and students will find invaluable insights that not only enrich academic scholarship but also inform effective public health interventions.

The American Journal of Public Health, published by the American Public Health Association, stands as a cornerstone in the field of public health and epidemiology since its inception in 1949. With its rigorous peer-review process and a robust commitment to advancing knowledge and research practices, this journal holds a prestigious position in the academic community, as reflected in its 2023 Scopus ranking, where it is placed in the top percentile (93rd) within the categories of Public Health and Environmental and Occupational Health. The journal's focus encompasses a broad spectrum of public health topics, making it essential reading for researchers, practitioners, and students dedicated to improving population health. Subscribers can access invaluable insights through its collection of innovative studies and reviews, thereby reinforcing the journal's role in shaping public health policy and practice. By bridging research and real-world application, the American Journal of Public Health remains a vital resource for those engaged in the quest to improve health outcomes across diverse communities.

REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES is a prestigious journal published by the OFFICE INTERNATIONAL DES EPIZOOTIES based in France, known globally for its commitment to advancing knowledge in the fields of Animal Science and Zoology as well as Medicine. With its ISSN 0253-1933 and E-ISSN 1608-0637, this journal has been a vital resource for researchers and practitioners since its establishment in 1990. Currently ranked in the Q3 quartile across both the Animal Science and Medicine categories in 2023, it reflects a growing impact in the veterinary community, holding commendable ranks in the veterinary general and miscellaneous categories. Although it does not offer open access options, its comprehensive articles are crucial for informing best practices, public health policies, and advancing research in veterinary medicine. With an emphasis on innovative approaches and evidence-based studies, the journal serves as a significant platform for networking and collaboration among scholars, professionals, and students dedicated to improving animal health and welfare worldwide.

Influenza and Other Respiratory Viruses, published by WILEY, serves as a prominent peer-reviewed platform for the dissemination of research contributing to the understanding and management of respiratory viral infections. With an impressive impact factor and established as an Open Access journal since 2014, it ensures maximum visibility and accessibility of pivotal research findings in the realm of Epidemiology, Infectious Diseases, Public Health, and Pulmonary and Respiratory Medicine. Registered under the ISSN 1750-2640 and E-ISSN 1750-2659, the journal boasts Q1 rankings in four critical categories as of 2023, underscoring its significance within the scientific community. Researchers, professionals, and students can benefit from the convergence of knowledge that this journal facilitates from 2007 to 2024, fostering advancements in understanding viral pathogens and innovative treatment strategies that are increasingly vital to public health efforts globally.